Sanofi Equity-NMS: SNY

Healthcare

Drug Manufacturers-General

Buy/Sell an entire stock
or a fraction.
Powered by Vested Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly
Loading, Please wait...
Error in Fetching Data, Please retry later.
No data available.
Previous close :$45.87
52W high :$57.92
1Y :-17.09%
5Y :-19.03%
EPS(TTM): :2.8
Shares O/S :2.53 B
Market cap :114.1 B

Compare with Other Stocks

Frequently Asked Questions

What is the share price of Sanofi today?

Sanofi (SNY) share price as of October 11, 2022, is $39.24. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of Sanofi?

Yes, Indian Investors can invest in the Sanofi (SNY) Share by opening an international trading account with Angel One.

How can I purchase Sanofi shares in India?

Purchasing Sanofi (SNY) share from India can be done by:
  1. Directly: By opening an international trading account with Angel One. The process would include KYC verification.
    The account activation takes a few minutes to a few hours, after which you can start buying Sanofi (SNY) by making deposits in US dollars.
  2. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of Sanofi?

Yes, you can purchase fractional shares of Sanofi (SNY) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of Sanofi?

The market capitalization of Sanofi on December 3, 2022, is $99.47 B.

In which sector Sanofi belongs?

Sanofi operates in the Healthcare sector, specifically in the Drug Manufacturers-General industry.

What documents are required to invest in Sanofi stocks?

In order to invest in Sanofi (SNY) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

About Sanofi

Sanofi SA is a healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme, among others.